Musalwa Muyangwa-Semanova

Musalwa Muyangwa-Semanova

Auto-generated profile, based on publicly available information

Musalwa Muyangwa-Semanova

University of Nottingham

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 May 2020 in Cancer Investigation
Verified
Journal Article
Closed access
LSLeissan R. Sadykova
Leissan R. Sadykova
ANAtara I. Ntekim
Atara I. Ntekim
MMMusalwa Muyangwa-Semenova
Musalwa Muyangwa-Semenova
CRCatrin Sian Rutland
Catrin Sian Rutland
JJJennie N. Jeyapalan
Jennie N. Jeyapalan
Albert A RizvanovAlbert A Rizvanov
Albert A Rizvanov
Osteosarcoma is a rare tumor diagnosed at any age; however younger age is a common risk factor. In addition, multiple factors are believed to contribute to higher rates of osteosarcoma, particularly race and gender. Although diagnosed worldwide, osteosarcoma is found to be more prevalent in Africa with high numbers of cases reported in Nigeria, Uganda, and Sudan. Additionally, higher rates are detected in African Americans, suggesting a genetic predisposition linked to race. This review focuses on identifying high risk factors of osteosarcoma with an emphasis on sarcoma epidemiology and risk factors in African countries.

27 November 2015 in Frontiers in Microbiology
Verified
Journal Article
Open access
MMMusalwa Muyangwa
Musalwa Muyangwa
EMEkaterina V. Martynova
Ekaterina V. Martynova
Svetlana KhaiboullinaSvetlana Khaiboullina
Svetlana Khaiboullina
SMSergey P. Morzunov
Sergey P. Morzunov
Albert A RizvanovAlbert A Rizvanov
Albert A Rizvanov
Hantaviruses are the members of the family Bunyaviridae that are naturally maintained in the populations of small mammals, mostly rodents. Most of these viruses can easily infect humans through contact with aerosols or dust generated by contaminated animal waste products. Depending on the particular hantavirus involved, human infection could result in either Hemorrhagic Fever with Renal Syndrome (HFRS) or in Hantavirus Cardiopulmonary Syndrome (HCPS). In the past few years, clinical cases of the hantavirus caused diseases have been on the rise. Understanding structure of the hantavirus genome and the functions of the key viral proteins is critical for the therapeutic agents’ research. This paper gives a brief overview of the current knowledge on the structure and properties of the hantavirus nucleoprotein and the glycoproteins.

27 August 2016 in BioNanoScience
Verified
Journal Article
Closed access
PDF file
MMM. Muyangwa
M. Muyangwa
EGE. E. Garanina
E. E. Garanina
EME. V. Martynova
E. V. Martynova
Albert A RizvanovAlbert A Rizvanov
Albert A Rizvanov

18 August 2025 in Epigenomics
Verified
Journal Article
Open access
RTRachel L. Thompson
Rachel L. Thompson
JLJennifer Lothion-Roy
Jennifer Lothion-Roy
EBEleanor Bellows
Eleanor Bellows
CWCorinne Woodcock
Corinne Woodcock
JJJorja Jackson-Oxley
Jorja Jackson-Oxley
AHAnna Elizabeth Harris
Anna Elizabeth Harris
Breast cancer (BCa) is one of the most commonly diagnosed malignancies worldwide and is clinically heterogenous. BCa is classified into distinct histopathological and molecular subtypes that inform diagnosis, treatment, and prognosis. Although therapeutic advances, particularly targeted therapies, have improved outcomes, metastatic BCa remains an unmet clinical need. In addition, treatment options remain limited especially for triple negative BCa (TNBC). There is an urgent need to develop novel approaches that can prevent, delay, or reverse disease progression in these patients. The roles of genetic and epigenetic alterations in BCa are well established. Emerging evidence highlights the dysregulation of epitranscriptomic mechanisms involving covalent RNA modifications as a contributing factor in BCa pathogenesis. Notably, recent evidence supports functional crosstalk between epigenetic and epitranscriptomic processes with potential clinical and therapeutic relevance. This review explores key epitranscriptomic RNA modifications, m6A, m6Am, m5C, m7G, and m1A in the context of BCa. The functional consequences of the epitranscriptomic regulators ("writers," "erasers", and "readers") are discussed alongside the accumulating evidence of their contribution to cancer development and progression. This review considers how RNA modifications and their regulators might serve as biomarkers or therapeutic targets and offers new directions for translational research and clinical intervention in BCa.